{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:36:12Z","timestamp":1783726572668,"version":"3.55.0"},"reference-count":23,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T00:00:00Z","timestamp":1662854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Sepsis is defined as a potentially fatal organ dysfunction induced by a dysregulated host response to infection [...]<\/jats:p>","DOI":"10.3390\/jcm11185332","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T01:44:03Z","timestamp":1663033443000},"page":"5332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Precision Medicine in Sepsis and Septic Shock"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1139-8547","authenticated-orcid":false,"given":"Alejandro","family":"Suarez-de-la-Rica","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Surgical Critical Care, Hospital Universitario Marqu\u00e9s de Valdecilla, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Maseda","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Surgical Critical Care, Hospital Universitario La Paz, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.21037\/atm.2016.08.59","article-title":"Epidemiologic trends of sepsis in western countries","volume":"4","author":"Gilsanz","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/bja\/aex234","article-title":"Epidemiology of sepsis and septic shock in critical care units: Comparison between sepsis-2 and sepsis-3 populations using a national critical care database","volume":"119","author":"Harrison","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.2014.2637","article-title":"Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012","volume":"311","author":"Kaukonen","year":"2014","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/cc12695","article-title":"Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012","volume":"17","author":"Zimmerman","year":"2013","journal-title":"Crit. Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1473-3099(12)70239-6","article-title":"Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: A prospective cohort study","volume":"12","author":"Levy","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00134-014-3496-0","article-title":"Surviving Sepsis Campaign: Association between performance metrics and outcomes in a 7.5-year study","volume":"40","author":"Levy","year":"2014","journal-title":"Intensive Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","article-title":"Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations","volume":"193","author":"Fleischmann","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","article-title":"Trial of Early, Goal-Directed Resuscitation for Septic Shock","volume":"372","author":"Mouncey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock","volume":"370","author":"Yealy","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"(2014). The ARISE Investigators and the ANZICS Clinical Trials Group Goal-Directed Resuscitation for Patients with Early Septic Shock. N. Engl. J. Med., 371, 1496\u20131506.","DOI":"10.1056\/NEJMoa1404380"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2019.22176","article-title":"Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock","volume":"323","author":"Fujii","year":"2020","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2020.11946","article-title":"Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock","volume":"324","author":"Moskowitz","year":"2020","journal-title":"JAMA J. Am. Med Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Fidalgo, P., Nora, D., Coelho, L., and Povoa, P. (2022). Pancreatic Stone Protein: Review of a New Biomarker in Sepsis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11041085"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin Alfa (Activated) in Adults with Septic Shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/17512433.2019.1643235","article-title":"Clinical trial design for unmet clinical needs: A spotlight on sepsis","volume":"12","author":"Vincent","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MCC.0000000000000834","article-title":"Hemodynamic clinical phenotyping in septic shock","volume":"27","author":"Daulasim","year":"2021","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5935\/0103-507X.20220004-en","article-title":"Hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial study protocol","volume":"34","author":"Kattan","year":"2022","journal-title":"Rev. Bras. Ter. Intensiva"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/01.CCM.0000145229.59014.6C","article-title":"Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab\u2032)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels","volume":"32","author":"Panacek","year":"2004","journal-title":"Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jinf.2016.01.010","article-title":"Defining immunological dysfunction in sepsis: A requisite tool for precision medicine","volume":"72","author":"Almansa","year":"2016","journal-title":"J. Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/phar.1974","article-title":"Metabolomics as a Driver in Advancing Precision Medicine in Sepsis","volume":"37","author":"Eckerle","year":"2017","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/18\/5332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:29:25Z","timestamp":1760142565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/18\/5332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,11]]},"references-count":23,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["jcm11185332"],"URL":"https:\/\/doi.org\/10.3390\/jcm11185332","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,11]]}}}